Early-Life Microbiome

Analyzing the gut microbiomes of children from birth through toddlerhood, researchers tie compositional changes to birth mode, infant diet, and antibiotic therapy.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

V. ALTOUNIAN/SCIENCE TRANSLATIONAL MEDICINEAnalyzing stool samples from 39 children in Finland for the first three years of their lives, a team led by investigators at the Broad Institute monitored the effects of factors including birth mode (vaginal versus Cesarean-section delivery) and the administration of antibiotics. Bacteroides bacteria dominated the gut microbiomes of most children born vaginally, while those born by C-section—and some of the vaginally delivered children—lacked Bacteroides for the first 6 to 18 months of their lives, the researchers reported yesterday (June 15) in Science Translational Medicine. Early-life antibiotic therapy was associated with less-diverse microbial communities overall, the researchers showed, and the 20 children who were treated with these drugs (for respiratory or ear infections) harbored antibiotic-resistance genes on microbial chromosomes and in mobile elements, some of which persisted beyond the completion of treatment.

“Regardless of their origin, our data suggest that the genomic context of the antibiotic resistance gene may influence its spread and persistence upon exposure to antibiotics,” the authors wrote in their paper. “Given the growing prevalence of antibiotic treatments and the frequency at which children exchange microbiota, it is particularly important to understand the effects of childhood antibiotic exposure on the presence and spread of antibiotic resistance genes in the community.”

Meanwhile, a team led by researchers at New York University (NYU) reported its analysis of microbiome development across 43 children in the U.S. for the first two years of the children’s lives. The team’s results, published yesterday in the same journal, show that birth mode, antibiotic treatment, and diet (breast milk– versus formula-dominant) all ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide